Persistent antinuclear antibodies in children without identifiable inflammatory rheumatic or autoimmune disease.
One hundred eight children with musculoskeletal pain considered not to be due to an autoimmune or inflammatory disease had an antinuclear antibody (ANA) test performed. Twenty-four of these children were ANA positive on HEp-2 cell substrate at a screening serum dilution of 1:20. A positive ANA test persisted in 21 of 24 of the patients over a mean time period of 38 months (range 1 to 103 months). No sera from any patient at initial evaluation had anti-DNA antibodies by radioimmunoassay or by indirect immunofluorescence on Crithidia luciliae. One patient recently developed elevated anti-DNA (radioimmunoassay) antibodies but still has a negative assay on C luciliae. Four patients had antibodies to core histones by immunoblotting. None had antibodies to Sm, RNP, Ro (SS-A), or La (SS-B) by counterimmunoelectrophoresis. No patient developed an overt inflammatory or autoimmune disease during a mean follow-up period of 61 months (range 13 to 138 months). A child with musculoskeletal pain and a positive test for ANA, but with no clinical evidence at presentation of inflammatory or autoimmune disease, is at low risk of imminently developing such a disease.
Cabral
D A
DA
Department of Pediatrics, University of British Columbia, Vancouver, Canada.
Petty
R E
RE
Fung
M
M
Malleson
P N
PN
D000293:Adolescent; D000974:Antibodies, Antinuclear / Q000032:analysis*; D001799:Blood Sedimentation; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D009140:Musculoskeletal Diseases / Q000097:blood / Q000209:etiology / Q000276:immunology*; D010146:Pain / Q000097:blood / Q000209:etiology / Q000276:immunology*
D000974:Antibodies, Antinuclear